Literature DB >> 8944860

Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin.

K Stark1, R Müller, U Bienzle, I Guggenmoos-Holzmann.   

Abstract

STUDY
OBJECTIVE: To determine whether methadone maintenance treatment (MMT) is effective in reducing the levels of HIV risk-taking behaviour (borrowing and lending of injection equipment, irregular condom use) among injecting drug users (IDUs), and to identify independent predictors of the borrowing of used syringes.
DESIGN: Cross sectional study of IDUs in MMT and not in MMT, using standardised interviews for collection of sociodemographic and behavioural data, and laboratory tests for detecting HIV antibodies. SETTING AND PARTICIPANTS: The 612 IDUs were recruited at different services for drug users such as treatment centres, walk in agencies, a hospital, and on the streets. MAIN
RESULTS: Of all IDUs, 41% had borrowed and 34% had passed on used injection equipment in the previous six months. In univariate analysis, IDUs receiving MMT had injected less frequently and were significantly less likely to borrow and lend syringes. In logistic regression analysis, MMT was protective against the borrowing of syringes (adjusted odds ratio 0.36, 95% confidence interval 0.2, 0.8), but not against syringe lending nor against sexual risk behaviour (i.e., numbers of sex partners, lack of condom use). Important independent predictors of the borrowing of syringes were injecting drug use in prison, use of sedatives, and sex with another IDU in the previous six months.
CONCLUSIONS: MMT may play a significant role in reducing the levels of borrowing of syringes among IDUs. However, additional prevention measures are needed which should specifically address sexual risk behaviour and target subgroups of IDUs with high levels of needle sharing, such as IDUs who have been in prison and and those who are sedative users.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944860      PMCID: PMC1060345          DOI: 10.1136/jech.50.5.534

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  18 in total

1.  International epidemiology of HIV and AIDS among injecting drug users.

Authors:  D C Des Jarlais; S R Friedman; K Choopanya; S Vanichseni; T P Ward
Journal:  AIDS       Date:  1992-10       Impact factor: 4.177

2.  HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam.

Authors:  C Hartgers; A van den Hoek; P Krijnen; R A Coutinho
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

3.  Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989.

Authors:  C F Robert; J J Déglon; J Wintsch; J L Martin; L Perrin; M Bourquin; V Gabriel; B Hirschel
Journal:  AIDS       Date:  1990-07       Impact factor: 4.177

4.  HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment.

Authors:  A Baker; N Kochan; J Dixon; A Wodak; N Heather
Journal:  Addiction       Date:  1995-04       Impact factor: 6.526

5.  Correlates of drug injection behaviors among methadone outpatients.

Authors:  S Y Kang; G De Leon
Journal:  Am J Drug Alcohol Abuse       Date:  1993       Impact factor: 3.829

Review 6.  Methadone maintenance and the human immunodeficiency virus: current issues in treatment and research.

Authors:  J Ward; S Darke; W Hall; R Mattick
Journal:  Br J Addict       Date:  1992-03

7.  Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City.

Authors:  D M Novick; H L Trigg; D C Des Jarlais; S R Friedman; D Vlahov; M J Kreek
Journal:  J Med Virol       Date:  1989-11       Impact factor: 2.327

8.  The course of the HIV epidemic among intravenous drug users in Amsterdam, The Netherlands.

Authors:  H J van Haastrecht; J A van den Hoek; C Bardoux; A Leentvaar-Kuypers; R A Coutinho
Journal:  Am J Public Health       Date:  1991-01       Impact factor: 9.308

9.  Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco.

Authors:  R E Chaisson; A R Moss; R Onishi; D Osmond; J R Carlson
Journal:  Am J Public Health       Date:  1987-02       Impact factor: 9.308

10.  Risk factors for human immunodeficiency virus infection in intravenous drug users.

Authors:  E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

View more
  12 in total

1.  A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany.

Authors:  K Stark; U Herrmann; S Ehrhardt; U Bienzle
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

Review 2.  Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection.

Authors:  Linda R Gowing; Michael Farrell; Reinhard Bornemann; Lynn E Sullivan; Robert L Ali
Journal:  J Gen Intern Med       Date:  2005-12-07       Impact factor: 5.128

3.  Sex, drugs, and HIV: does methadone maintenance reduce drug use and risky sexual behavior?

Authors:  C M Lollis; H S Strothers; D D Chitwood; M McGhee
Journal:  J Behav Med       Date:  2000-12

4.  Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.

Authors:  H Thiede; H Hagan; C S Murrill
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

5.  The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary.

Authors:  V Anna Gyarmathy; József Rácz; Alan Neaigus; Eszter Ujhelyi
Journal:  AIDS Educ Prev       Date:  2004-06

6.  Individual and social factors associated with participation in treatment programs for drug users.

Authors:  V Anna Gyarmathy; Carl A Latkin
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

7.  A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners.

Authors:  Sandra A Springer; Robert D Bruce
Journal:  J Opioid Manag       Date:  2008 Mar-Apr

8.  Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance.

Authors:  Jessica Willner-Reid; Katherine A Belendiuk; David H Epstein; John Schmittner; Kenzie L Preston
Journal:  J Subst Abuse Treat       Date:  2007-10-10

9.  Cost-effectiveness of Methadone Maintenance Treatment in Prevention of HIV Among Drug Users in Shiraz, South of Iran.

Authors:  Ali Keshtkaran; Alireza Mirahmadizadeh; Alireza Heidari; Mehdi Javanbakht
Journal:  Iran Red Crescent Med J       Date:  2014-01-05       Impact factor: 0.611

10.  Inconsistent Condom Use among Iranian Male Drug Injectors.

Authors:  Shervin Assari; Mosaieb Yarmohmmadi Vasel; Mahmood Tavakoli; Mahmoud Sehat; Firoozeh Jafari; Hooman Narenjiha; Hassan Rafiey; Khodabakhsh Ahmadi
Journal:  Front Psychiatry       Date:  2014-04-04       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.